Macarena Hernandez, aptaTargets S.L., Madrid; Francisco Abad-Santos, Dept of Pharmacology and Toxicology, Faculty of Med, Univ Complutense, Madrid, Spain, Madrid, Spain; Ian Cotgreave, Karolinska Inst, Stockholm, Sweden; Jaime Gallego Sr., Complejo Hospario de Navarra, Pamplona; Bernd Jilma, MEDICAL UNIVERSITY OF VIENNA, Vienna; Alan Flores Flores, Hosp Joan XXIII, Tarragona; Tudor G Jovin, Cooper Neurological Inst, Camden, NJ; José Vivancos, Hosp de la Princesa, Madrid, Spain; Maria Hernandez-Perez, Germans Trias i Pujol Hosp, Barcelona; Carlos A Molina, HOSPITAL VALL D HEBRON, Barcelona; Joan Montaner, Hosp Macarena Seville, IBIS, seville; JOAQUIN CASARIEGO, Aldebaran Res Development SL, Majadahonda; Mads Dalsgaard, Cureteq, Frederiksberg; David S Liebeskind, Erik Cobo, UCLA, Los Angeles, CA; Maria del Mar Castellanos, Hosp Juan Canalejo, LA Coruña, Spain; Pedro Cardona, BELLVITGE HOSPITAL, Barcelona; Jaime Masjuan, HOSPITAL UNIVERSITARIO RAMN Y CAJAL, Madrid, Spain; Francisco Moniche Sr., HOSPITAL VIRGEN DEL ROCIO, Seville; Jose Tembl, HOSPITAL VIRGEN DEL ROCIO, Seville, Valencia; Mikel Terceño, HOSPITAL VIRGEN DEL ROCIO, Seville, Valencia, Girona; Juan F Arenillas, HOSPITAL CLINICO UNIV VALLADOLID, Valladolid; Patricia Calleja, Hosp 12 de Octubre, Madrid, Spain; Lionel Calviere, CHU RANGUEIL, Toulouse, France; Jean Marc M Olivot, HOPITAL TOULOUSE PURPAN, Toulouse, France; Hilde Henon, Univ of Lille, Lille, France; Mikael Mazighi, Fondation Rothschild, Paris, France; Marc Ribo, HOSPITAL VALL D HEBRON, Barcelona, Spain

M.Hernandez: Employee; ; aptaTargets S.L.. C.A.Molina: None. J.Montaner: n/a. J.Casariego: Advisor; ; APTA TARGETS, Consultant; ; STEMLINE THERAPEUTICS, Employee; ; JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON, STEMLINE THERAPEUTICS, Independent Contractor; ; JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON, Individual Stocks/Stock Options; ; JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON. M.Dalsgaard: Individual Stocks/Stock Options; ; Aptatargets , Lundbeck a/s, Novonordisk a/s, Cureteq AG. D.S.Liebeskind: Consultant; ; Cerenovus, Genentech, Medtronic, Stryker, Rapid Medical. E.Cobo: Advisor; ; aptaTargets. M.Castellanos: n/a. P.Cardona: None. J.Masjuan: Researcher; ; APP TARGET. F.Moniche: None. F.Abad-santos: Consultant; ; AptaTargets, Researcher; ; Laboratorios Alter , Laboratorios NORMON, Janssen, GSK, MSD, Moderna. J.Tembl: n/a. M.Terceño: None. J.F.Arenillas: Advisor; ; BMS-Pfizer, Consultant; ; Medtronic, Medtronic, Amgen, Other; ; Daichii-Sankyo, Researcher; ; Astra-Zeneca, Speaker; ; BMS-Pfizer, Medtronic, Boehringer-Ingelheim, Bayer. P.Calleja: None. L.Calviere: Other; ; Pfizer. J.M.Olivot: Consultant; ; Abbvie, Bioxodes, Acticor, Speaker; ; Bristol Myers Squibb, Boehringer . H.Henon: Speaker; ; SANOFI. M.Mazighi: Consultant; ; Acticor Biotech, Boerhinger Ingelheim, Novonordisk, Alexion. M.Ribo: Advisor; ; Apta targets, Consultant; ; Medtronic, Cerenovus, Philips, Individual Stocks/Stock Options; ; Methinks, Ownership Interest; ; Anaconda, NoraHealth. I.Cotgreave: None. J.Gallego: Other; ; aptaTargets. B.Jilma: Consultant; ; AptaTarget. A.F.Flores: None. T.G.Jovin: Advisor; ; Cerenovus, Individual Stocks/Stock Options; ; Route 92, Galaxy Therapeutics, Merhinks, Anaconda , Viz.ai, Kandu Health, StataDX , Ownership Interest; ; FreeOx Biotech, Research Funding (PI or named investigator); ; Stryker, Medtronic. J.Vivancos: n/a. M.Hernandez-perez: Advisor; ; ApToll , Employee; ; Mehinks AI.